Scilex Holding (SCLX) Inventory Average (2023 - 2026)
Scilex Holding (SCLX) posted quarterly Inventory Average of $4.7 million for Q1 2026, up 70.93% year-over-year from $2.7 million in Q1 2025, and up 58.76% quarter-over-quarter from $2.9 million in Q4 2025.
Scilex Holding (SCLX) Inventory Average (2023 - 2026) Analysis & Trends
Scilex Holding's Inventory Average history runs 4 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Inventory Average rose 70.93% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 70.93% YoY), while the FY2025 annual figure was $3.6 million, up 8.65% from the prior year.
- Inventory Average for Q1 2026 stood at $4.7 million, up from $2.9 million in the prior quarter.
- The five-year high for Inventory Average was $4.7 million in Q1 2026, with the low at $1.8 million in Q3 2025.
- The 4-year median for Inventory Average is $2.8 million (2025), against an average of $3.0 million.
- Peak annual rise in Inventory Average reached 110.79% in 2024, while the deepest fall reached 40.66% in 2024.
- Scilex Holding's Inventory Average stood at $4.1 million in 2023, then sank by 40.66% to $2.4 million in 2024, then gained by 21.3% to $2.9 million in 2025, then jumped by 58.76% to $4.7 million in 2026.
- Business Quant data shows SCLX's Inventory Average at $4.7 million in Q1 2026, $2.9 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 470.31 Bn | 463.74 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 377.07 Bn | 369.93 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 303.14 Bn | 295.45 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 236.33 Bn | 222.34 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 182.14 Bn | 178.96 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 106.20 Bn | 102.03 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Scilex Holding | 39.49 Mn | -73.30 Mn | 3.97 Mn | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.66 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 3.53 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 1.83 Mn |